Medical Condition News

RSS

Discovery may lead to new anti-metastasis therapies for advanced-stage brain cancer patients

It's no surprise that people enjoy warm places like Hawaii but may suffer in hostile locales such as Antarctica. A tumor suppressor gene called PTEN is similar in that it is affected by the microenvironments of certain bodily organs to which it travels.

20 Oct 2015

Low levels of stem cell factor associated with increased risk of cardiovascular disease

New research indicates that low levels of a growth factor called stem cell factor (SCF)--which is thought to be important for blood vessel repair--are linked with an increased risk of cardiovascular disease.

20 Oct 2015

Sleep apnea may increase gout risk

Sleep apnea may increase the risk of developing gout, a new study shows. Among 9865 patients with newly-diagnosed sleep apnea and 43,598 comparators of similar weight, investigators identified 270 new cases of gout over one year of follow-up, resulting in incidence rates of 8.4/1000 and 4.8/1000 person-years, respectively. The increased risk of gout was 60% higher among patients with sleep apnea.

20 Oct 2015

Use of hearing aids may help safeguard memory and thinking skills in older adults

Hearing loss is linked with accelerated cognitive decline in older adults, but the use of hearing aids may help safeguard seniors' memory and thinking skills.

20 Oct 2015

New MRI study shows heart ages differently in men and women

A federally funded analysis of MRI scans of the aging hearts of nearly 3,000 adults shows significant differences in the way male and female hearts change over time.

20 Oct 2015

Chemotherapy-induced nausea and vomiting most common distressing symptoms in majority of cancer patients

Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc., found that 83% of patients receiving chemotherapy who have experienced chemotherapy-induced nausea and vomiting (CINV) believe it is a side effect with which they must live.

20 Oct 2015

ESPU, ICCS launch World Bedwetting Day to raise awareness among children and families

The International Children’s Continence Society and the European Society for Paediatric Urology announced today the launch of World Bedwetting Day at the 26th ESPU Congress in Prague.

20 Oct 2015

Diabetes expert calls for self-management education programmes in light of systematic failures

People with diabetes denied access to education are being let down by "systematic failures", according to a leading researcher.

20 Oct 2015

Celiac patients at no increased risk for dementia, study finds

A new and comprehensive study by investigators at the Celiac Disease Center at Columbia University Medical Center has found that celiac patients are at no increased risk for dementia before or after their diagnosis of celiac disease.

20 Oct 2015

Study explores relative role of traumatization, PTSD on sexual behavior and well-being

Among 96 former Swiss indentured child laborers, 22 individuals showed post-traumatic stress disorder (PTSD) symptoms and 53 reported having experienced childhood trauma. Men reported a significantly higher prevalence of both sexual concerns and dysfunctional sexual behavior compared with women.

20 Oct 2015

NAM announces election of three new members from UC San Diego School of Medicine

The National Academy of Medicine announced today the election of three new members from University of California, San Diego School of Medicine: Napoleone Ferrara, MD; Christopher K. Glass, MD, PhD; and Roberto Malinow, MD, PhD. Election to NAM is considered among the highest honors in the fields of health and medicine.

20 Oct 2015

TSRI researchers find way to change leukemia cells into leukemia-killing immune cells

Scientists at The Scripps Research Institute have found a way to change leukemia cells into leukemia-killing immune cells. The surprise finding could lead to a powerful new therapy for leukemia and possibly other cancers.

20 Oct 2015

Takeda highlights safety, efficacy of vedolizumab for UC and CD at ACG Annual Scientific Meeting

Takeda Pharmaceuticals, U.S.A., Inc., today announced that data highlighting the efficacy and safety of vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), will be presented during the 2015 American College of Gastroenterology Annual Scientific Meeting in Honolulu, Hawaii, held on October 16-21.

20 Oct 2015

Ember Therapeutics reports initial results from BMP-7 Phase II trial in patients with moderate osteoarthritis of the knee

Ember Therapeutics, Inc., a privately held, New York-based biopharmaceutical company that is developing targeted therapies for osteoarthritis, kidney fibrosis, and other indications using Bone Morphogenetic Protein (BMP)-7, announced today initial results from the Phase II(a) trial of local BMP-7 administration in patients with moderate osteoarthritis of the knee.

20 Oct 2015

Kaiser Permanente recognizes three projects for advancing quality and patient safety to transform care

As part of Kaiser Permanente's culture of continuous improvement, the organization annually recognizes outstanding projects across the nation's largest integrated health system that advance quality and patient safety. Recently, three winners were honored for their efforts in supporting patient care through technology, advanced sepsis intervention and improving early detection of diabetic retinopathy.

20 Oct 2015

Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

In the UK there are currently over 3.5 million people who have diabetes, with a growth rate exceeding 280,000 people per year. Diabetic retinopathy is the most common complication of diabetes.

19 Oct 2015

Lexicon's telotristat etiprate improves social and physical function, emotional well-being in cancer patients

Lexicon Pharmaceuticals, Inc.'s telotristat etiprate, the first oral therapy in development for the treatment of carcinoid syndrome (CS), was associated with patient-reported improvements in social and physical function and emotional well-being according to new exit interview data from the Phase 3 TELESTAR study presented at the 2015 Neuroendocrine Tumor Society Annual Symposium in Austin, Texas.

19 Oct 2015

LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis

LEO Pharma Inc., a wholly owned U.S. subsidiary of LEO Pharma A/S, announced today that Enstilar has been approved by the U.S. Food and Drug Administration for the topical treatment of plaque psoriasis in adults 18 years of age and older.

19 Oct 2015

Sequenom enters into clinical collaboration with CU School of Medicine

Sequenom, Inc., a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced that it has entered into a clinical collaboration with the University of Colorado Denver, School of Medicine.

19 Oct 2015

Latest research on thyroid cancer to be highlighted at 15th International Thyroid Congress

The effect of radiation exposure related to the nuclear accidents that took place in Fukushima, Japan, and Chernobyl, Ukraine on thyroid cancer risk, whether dietary habits influence the risk of developing thyroid cancer, and recent study results with a triiodothyronine (T3) analog in an uncommon form of thyroid disease are all topics featured in oral presentations delivered at the 15th International Thyroid Congress, hosted by the American Thyroid Association, October 18-23, 2015, in Orlando, Florida.

19 Oct 2015

Medical Condition News

Discovery may lead to new anti-metastasis therapies for advanced-stage brain cancer patients

Low levels of stem cell factor associated with increased risk of cardiovascular disease

Sleep apnea may increase gout risk

Use of hearing aids may help safeguard memory and thinking skills in older adults

New MRI study shows heart ages differently in men and women

Chemotherapy-induced nausea and vomiting most common distressing symptoms in majority of cancer patients

ESPU, ICCS launch World Bedwetting Day to raise awareness among children and families

Diabetes expert calls for self-management education programmes in light of systematic failures

Celiac patients at no increased risk for dementia, study finds

Study explores relative role of traumatization, PTSD on sexual behavior and well-being

NAM announces election of three new members from UC San Diego School of Medicine

TSRI researchers find way to change leukemia cells into leukemia-killing immune cells

Takeda highlights safety, efficacy of vedolizumab for UC and CD at ACG Annual Scientific Meeting

Ember Therapeutics reports initial results from BMP-7 Phase II trial in patients with moderate osteoarthritis of the knee

Kaiser Permanente recognizes three projects for advancing quality and patient safety to transform care

Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

Lexicon's telotristat etiprate improves social and physical function, emotional well-being in cancer patients

LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis

Sequenom enters into clinical collaboration with CU School of Medicine

Latest research on thyroid cancer to be highlighted at 15th International Thyroid Congress

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News